Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5498

1.

The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery.

Bartlett FR, Colgan RM, Donovan EM, McNair HA, Carr K, Evans PM, Griffin C, Locke I, Haviland JS, Yarnold JR, Kirby AM.

Radiother Oncol. 2015 Jan;114(1):66-72. doi: 10.1016/j.radonc.2014.11.018. Epub 2014 Nov 26.

PMID:
25739317
2.

Ewing sarcoma in adults treated with modern radiotherapy techniques.

Casey DL, Meyers PA, Alektiar KM, Magnan H, Healey JH, Boland PJ, Wolden SL.

Radiother Oncol. 2014 Nov;113(2):248-53. doi: 10.1016/j.radonc.2014.11.023. Epub 2014 Nov 26.

PMID:
25613397
3.

Proposed revision of CT-based cervical and thoracic lymph node levels for esophageal cancer in UICC 7th version.

Liu M, Chen Y, Fu X, Zhao K, Jiang GL.

Radiother Oncol. 2014 Nov;113(2):175-81. doi: 10.1016/j.radonc.2014.11.022. Epub 2014 Nov 26.

PMID:
25613396
4.

Reirradiation of locally recurrent rectal cancer: a systematic review.

Guren MG, Undseth C, Rekstad BL, Brændengen M, Dueland S, Spindler KL, Glynne-Jones R, Tveit KM.

Radiother Oncol. 2014 Nov;113(2):151-7. doi: 10.1016/j.radonc.2014.11.021. Epub 2014 Nov 26. Review.

5.

Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?

Beukema JC, van Luijk P, Widder J, Langendijk JA, Muijs CT.

Radiother Oncol. 2015 Jan;114(1):85-90. doi: 10.1016/j.radonc.2014.11.037. Epub 2014 Dec 30. Review.

PMID:
25554226
6.

Dosimetric analysis of urethral strictures following HDR (192)Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer.

Díez P, Mullassery V, Dankulchai P, Ostler P, Hughes R, Alonzi R, Lowe G, Hoskin PJ.

Radiother Oncol. 2014 Dec;113(3):410-3. doi: 10.1016/j.radonc.2014.10.007. Epub 2014 Nov 26.

PMID:
25544648
7.

Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.

Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG, Overgaard J; Danish Head and Neck Cancer Group (DAHANCA).

Radiother Oncol. 2014 Dec;113(3):310-6. doi: 10.1016/j.radonc.2014.11.032. Epub 2014 Nov 26.

8.

Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma.

Greenfield BJ, Okcu MF, Baxter PA, Chintagumpala M, Teh BS, Dauser RC, Su J, Desai SS, Paulino AC.

Radiother Oncol. 2015 Feb;114(2):224-9. doi: 10.1016/j.radonc.2014.11.035. Epub 2014 Dec 23.

PMID:
25542650
9.

Passive breath gating equipment for cone beam CT-guided RapidArc gastric cancer treatments.

Hu W, Li G, Ye J, Wang J, Peng J, Gong M, Yu X, Studentski MT, Xiao Y, Zhang Z.

Radiother Oncol. 2015 Jan;114(1):104-8. doi: 10.1016/j.radonc.2014.11.046. Epub 2014 Dec 18.

PMID:
25532907
10.

In response to "histopathologic validation of 3'-deoxy-3'-(18)F-fluorothymidine PET for detecting tumour repopulation during fractionated radiotherapy in human FaDu squamous cell carcinoma in nude mice".

Troost EG, Hoeben BA, Laverman P, Bussink J, Oyen WJ.

Radiother Oncol. 2015 Mar;114(3):417-8. doi: 10.1016/j.radonc.2014.11.040. Epub 2014 Dec 12. No abstract available.

PMID:
25511411
11.

Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines.

Leon O, Guren M, Hagberg O, Glimelius B, Dahl O, Havsteen H, Naucler G, Svensson C, Tveit KM, Jakobsen A, Pfeiffer P, Wanderås E, Ekman T, Lindh B, Balteskard L, Frykholm G, Johnsson A.

Radiother Oncol. 2014 Dec;113(3):352-8. doi: 10.1016/j.radonc.2014.10.002.

PMID:
25499203
12.

Comparison of toxicity after IMRT and 3D-conformal radiotherapy for patients with pancreatic cancer - a systematic review.

Bittner MI, Grosu AL, Brunner TB.

Radiother Oncol. 2015 Jan;114(1):117-21. doi: 10.1016/j.radonc.2014.11.043. Epub 2014 Dec 11. Review.

PMID:
25497876
13.

Cardiac volume effects during chemoradiotherapy for esophageal cancer (Regarding Lutkenhaus et al. Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer).

Edmunds K, Brooks C, Hansen VN, Harris V, Tait DM.

Radiother Oncol. 2015 Jan;114(1):128-9. doi: 10.1016/j.radonc.2014.11.041. Epub 2014 Dec 10. No abstract available.

PMID:
25497875
14.

Can perfusion MRI predict response to preoperative treatment in rectal cancer?

Martens MH, Subhani S, Heijnen LA, Lambregts DM, Buijsen J, Maas M, Riedl RG, Jeukens CR, Beets GL, Kluza E, Beets-Tan RG.

Radiother Oncol. 2015 Feb;114(2):218-23. doi: 10.1016/j.radonc.2014.11.044. Epub 2014 Dec 10.

PMID:
25497874
15.

Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons.

Louie AV, Palma DA, Dahele M, Rodrigues GB, Senan S.

Radiother Oncol. 2015 Feb;114(2):138-47. doi: 10.1016/j.radonc.2014.11.036. Epub 2014 Dec 10. Review.

PMID:
25497873
16.

Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.

Mazeron R, Castelnau-Marchand P, Dumas I, del Campo ER, Kom LK, Martinetti F, Farha G, Tailleur A, Morice P, Chargari C, Lefkopoulos D, Haie-Meder C.

Radiother Oncol. 2015 Feb;114(2):257-63. doi: 10.1016/j.radonc.2014.11.045. Epub 2014 Dec 10.

PMID:
25497872
17.

Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer.

Bao Y, Peng F, Zhou QC, Yu ZH, Li JC, Cheng ZB, Chen L, Hu X, Chen YY, Wang J, Wang Y, Ma HL, Xu ZM, Lu RB, Deng XW, Chen M.

Radiother Oncol. 2015 Feb;114(2):161-6. doi: 10.1016/j.radonc.2014.11.039. Epub 2014 Dec 9.

PMID:
25497558
18.

Heart dose reduction by prone deep inspiration breath hold in left-sided breast irradiation.

Mulliez T, Veldeman L, Speleers B, Mahjoubi K, Remouchamps V, Van Greveling A, Gilsoul M, Berwouts D, Lievens Y, Van den Broecke R, De Neve W.

Radiother Oncol. 2015 Jan;114(1):79-84. doi: 10.1016/j.radonc.2014.11.038. Epub 2014 Dec 9.

PMID:
25497557
19.

Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Qi WX, Fu S, Zhang Q, Guo XM.

Radiother Oncol. 2015 Mar;114(3):289-95. doi: 10.1016/j.radonc.2014.11.033. Epub 2014 Dec 9. Review.

PMID:
25497556
20.

Which benefits and harms of preoperative radiotherapy should be addressed? A Delphi consensus study among rectal cancer patients and radiation oncologists.

Kunneman M, Pieterse AH, Stiggelbout AM, Marijnen CA.

Radiother Oncol. 2015 Feb;114(2):212-7. doi: 10.1016/j.radonc.2014.11.034. Epub 2014 Dec 11.

Supplemental Content

Loading ...
Support Center